These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9808683)

  • 1. Selective cyclooxygenase-2 inhibition by nimesulide in man.
    Cullen L; Kelly L; Connor SO; Fitzgerald DJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):578-82. PubMed ID: 9808683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings.
    Panara MR; Padovano R; Sciulli MG; Santini G; Renda G; Rotondo MT; Pace A; Patrono C; Patrignani P
    Clin Pharmacol Ther; 1998 Jun; 63(6):672-81. PubMed ID: 9663182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.
    Kearney D; Byrne A; Crean P; Cox D; Fitzgerald DJ
    J Am Coll Cardiol; 2004 Feb; 43(4):526-31. PubMed ID: 14975458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
    Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
    Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
    Gray PA; Warner TD; Vojnovic I; Del Soldato P; Parikh A; Scadding GK; Mitchell JA
    Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
    McAdam BF; Catella-Lawson F; Mardini IA; Kapoor S; Lawson JA; FitzGerald GA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):272-7. PubMed ID: 9874808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.
    Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW
    Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
    Patrignani P; Sciulli MG; Manarini S; Santini G; Cerletti C; Evangelista V
    J Physiol Pharmacol; 1999 Dec; 50(4):661-7. PubMed ID: 10639016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by nimesulide of prostaglandin production in rat macrophages.
    Taniguchi Y; Yokoyama K; Ikesue A; Noda K; Debuchi H; Nakamura T; Toda A; Shimeno H
    Drugs Exp Clin Res; 1998; 24(1):17-27. PubMed ID: 9604145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
    Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis.
    Duffy T; Belton O; Bresnihan B; FitzGerald O; FitzGerald D
    Drugs; 2003; 63 Suppl 1():31-6. PubMed ID: 14506909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo assessment of nimesulide cyclooxygenase-2 selectivity.
    Shah AA; Murray FE; Fitzgerald DJ
    Rheumatology (Oxford); 1999 May; 38 Suppl 1():19-23. PubMed ID: 10369402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine.
    Gross GJ; Moore J
    Pharmacology; 2004 Jul; 71(3):135-42. PubMed ID: 15161995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
    Famaey JP
    Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nimesulide action time dependence on selectivity towards prostaglandin G/H synthase/cyclooxygenase activity.
    Vago T; Bevilacqua M; Norbiato G
    Arzneimittelforschung; 1995 Oct; 45(10):1096-8. PubMed ID: 8595067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing profiles of prostaglandin formation inhibition between selective prostaglandin H synthase-2 inhibitors and conventional NSAIDs in inflammatory and non-inflammatory sites of the rat.
    Harada Y; Kawamura M; Hatanaka K; Saito M; Ogino M; Ohno T; Ogino K; Yang Q
    Prostaglandins Other Lipid Mediat; 1998 Apr; 55(5-6):345-58. PubMed ID: 9653772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.